Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.
Synerkine Pharma has raised €12M across 3 funding rounds from 5 investors, most recently a Series A round in Oct 2023. Based in Utrecht, Netherlands; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-10-13 | Series A | €5.3M | Flerie Invest,InnovationQuarter Capital,Thuja Capital,Utrecht Health Seed Fund | View deal → |
| 2021-12-17 | Series A | €3.5M | Flerie Invest,Thuja Capital,Utrecht Holdings | View deal → |
| 2019-01-01 | Series A | €3.3M | Thuja Capital | View deal → |
